Search research articles
Contact Us
Filters
Showing results (201-210 of 395) with videos related to
Page
of 40
Sort By:
The Journal of Rheumatology
|
June 2, 2004
Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
Maurizio Rizzi, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Autoimmunity Reviews
|
September 22, 2010
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies
Caterina Defendenti, Fabiola Atzeni, Maria Francesca Spina, et al.
Clinical and Experimental Rheumatology
|
February 13, 2019
Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography
Roberto Casale, Gennaro Boccia, Zaira Symeonidou, et al.
Biomed Research International
|
August 12, 2014
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry
Matteo Filippini, Chiara Bazzani, Fabiola Atzeni, et al.
Arthritis Research & Therapy
|
December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
Expert Review of Clinical Immunology
|
July 26, 2022
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment
Luca Quartuccio, Marco Sebastiani, Francesca Romana Spinelli, et al.
Autoimmunity Reviews
|
October 18, 2017
Rheumatic diseases and autoimmune vascular dementia
Fabiola Atzeni, Nicolò Pipitone, Luca Iaccarino, et al.
Therapeutic Advances in Musculoskeletal Disease
|
March 1, 2021
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
Giovanni Adami, Elisabetta Gerratana, Fabiola Atzeni, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 20, 2020
Toxicological considerations in the treatment of axial spondylo-arthritis
Francesca Marino, Salvatore D'Angelo, Ignazio Francesco Masala, et al.
Autoimmunity Reviews
|
January 2, 2010
Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry
Roberto Caporali, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Page
of 40
Search research articles
Search
Showing results (201-210 of 395) with videos related to
Sort By:
Page
of 40
The Journal of Rheumatology
|
June 2, 2004
Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
Maurizio Rizzi, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Autoimmunity Reviews
|
September 22, 2010
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies
Caterina Defendenti, Fabiola Atzeni, Maria Francesca Spina, et al.
Clinical and Experimental Rheumatology
|
February 13, 2019
Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography
Roberto Casale, Gennaro Boccia, Zaira Symeonidou, et al.
Biomed Research International
|
August 12, 2014
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry
Matteo Filippini, Chiara Bazzani, Fabiola Atzeni, et al.
Arthritis Research & Therapy
|
December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
Expert Review of Clinical Immunology
|
July 26, 2022
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment
Luca Quartuccio, Marco Sebastiani, Francesca Romana Spinelli, et al.
Autoimmunity Reviews
|
October 18, 2017
Rheumatic diseases and autoimmune vascular dementia
Fabiola Atzeni, Nicolò Pipitone, Luca Iaccarino, et al.
Therapeutic Advances in Musculoskeletal Disease
|
March 1, 2021
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
Giovanni Adami, Elisabetta Gerratana, Fabiola Atzeni, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 20, 2020
Toxicological considerations in the treatment of axial spondylo-arthritis
Francesca Marino, Salvatore D'Angelo, Ignazio Francesco Masala, et al.
Autoimmunity Reviews
|
January 2, 2010
Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry
Roberto Caporali, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Page
of 40